A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group (Q35314724)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

title

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

main subject

ocular hypertension

1 reference

based on heuristic

inferred from title

latanoprost

1 reference

based on heuristic

inferred from title

author name string

O'Donoghue EP

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

published in

British Journal of Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

volume

84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

page(s)

579-582

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

cites work

Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

retrieved

27 July 2018

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

retrieved

26 September 2018

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

retrieved

26 September 2018

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

retrieved

26 September 2018

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

retrieved

26 September 2018

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10837379

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10837379

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Dorzolamide and Timolol as Suppressors of Aqueous Humor Flow in Humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10837379

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/10837379

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BJO.84.6.579

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

PMC publication ID

1723499

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

PubMed publication ID

10837379

1 reference

stated in

Europe PubMed Central

PubMed publication ID

10837379

retrieved

7 August 2017

ResearchGate publication ID

12481645

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35314724&oldid=1639219458"